Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin family member 9 (KIF9) is a highly conserved molecular motor protein that moves along microtubules and is part of the kinesin superfamily. KIF9 is predominantly expressed in motile ciliated cells, especially in testicular tissue and in spermatozoa, where it localizes to the central pair of axonemal microtubules. It is essential for the regulation of ciliary and flagellar motility, with its absence leading to defects in progressive sperm motility and male subfertility due to changes in flagellar waveform and compromised ciliary beating. Structural studies indicate KIF9 helps maintain proper localization of central pair proteins, radial spokes, and dynein arms at the axonemal tip. In mammals, loss of function mutations in KIF9 have been linked to asthenozoospermia and other motile ciliopathies, but there are no validated drugs targeting KIF9 and no known direct safety or adverse effect concerns in pharmacology.[2][5][7] KIF9 is critical for ciliary beating—its evolutionary conserved function is to regulate motility in cells with motile cilia or flagella, primarily by interacting with the central pair microtubules and central pair proteins such as HYDIN[2][5][7]. Knockout studies in mice and humans show loss of KIF9 impairs sperm motility, causing circular swimming patterns and reduced fertilization efficiency, consistent with a key role in sperm flagellar function[2][7]. Molecularly, KIF9 is classified among kinesins and is distinct from druggable enzyme classes; it is not currently viewed as a therapeutic receptor, enzyme, or transporter[3][6]. There are no reports of pharmacological agents targeting KIF9 or of established roles as a biomarker in therapeutic patient selection outside of research/diagnostic contexts[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 9 (KIF9).